The Moat Index
Compare moats, side by side.
Two to four companies, scored on the same five investor questions from their SEC filings — so the comparison is apples to apples. The method is fully public.
HCIL · Healthcare · Shallow moat
Doesn't clear the bar
The balanceSheet component abstained: Insufficient leverage/coverage inputs to score the balance sheet. The other four 20% weights were renormalized over the scored 80%.
| Measure | ADMT | TRNS | AORT | HCIL |
|---|---|---|---|---|
| Moat Score (0–100) | 40 (highest) | 40 (highest) | 40 (highest) | 40 (highest) |
| Methodology version | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 | moat-index@3.0.0 |
| Business trend | 59 | 60 | 75 (highest) | 63 |
| Pricing power | 65 | 39 | 100 (highest) | 53 |
| Returns on capital | 4 | 17 (highest) | 0 | 0 |
| Balance-sheet safety | 28 (highest) | 24 | 18 | — |
| Capital allocation | 44 | 60 (highest) | 7 | 44 |
| No price data | 412% above value if growth stopped today | No price data | No price data | |
| Market cap | $2.7M | $792M | $1.2B | Not reported |
| Moat tier | Shallow moat | Shallow moat | Shallow moat | Shallow moat |
| Filing date | FY2026 | FY2026 | FY2025 | FY2025 |